Related Experiment Video
Updated: Jun 18, 2026

Dithranol as a Matrix for Matrix Assisted Laser Desorption/Ionization Imaging on a Fourier Transform Ion Cyclotron Resonance Mass Spectrometer
Published on: November 27, 2013
Dermatan sulphate in haemodialysis
1Department of Haematology, Charing Cross and Westminster Hospital and Medical School, London, UK.
Dermatan sulfate effectively inhibits blood clots in patients undergoing hemodialysis. This antithrombotic agent shows promise as a safer alternative to heparin for preventing thrombosis.
Area of Science:
- Pharmacology
- Hematology
- Nephrology
Background:
- Dermatan sulfate exhibits antithrombotic properties, potentially inhibiting venous thrombi with less bleeding risk than heparin.
- Unlike heparin, which targets antithrombin III, dermatan sulfate selectively inhibits thrombin via heparin co-factor II.
Purpose of the Study:
- To evaluate the efficacy and safety of dermatan sulfate as an anticoagulant and antithrombotic agent.
- To conduct dose-finding studies for dermatan sulfate in patients requiring maintenance hemodialysis.
Main Methods:
- Dose-finding studies were performed.
- The study population comprised patients on maintenance hemodialysis.
Main Results:
- Dermatan sulfate demonstrated effectiveness as an anticoagulant in the studied patient group.
- The agent showed potential for antithrombotic activity.
Conclusions:
- Dermatan sulfate is an effective anticoagulant in patients undergoing maintenance hemodialysis.
- Further research into dermatan sulfate's antithrombotic potential is warranted.
Related Concept Videos
SDS-PAGE
A variation of gel electrophoresis, termed polyacrylamide gel electrophoresis (PAGE), is commonly used for separating proteins according to their molecular size by passing them through a polyacrylamide gel. Because of the varying charges associated with amino acid side chains, PAGE can be used to separate intact proteins...
Masking and Demasking Agents
There are many masking agents, such as cyanide, fluoride, triethanolamine, thiourea, and 2,3-bis(sulfanyl)propan-1-ol (formerly 2,3-dimercapto-1-propanol), with the masking agent chosen based on the metal...
Dialysis
Dialysis
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis
Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration

